vs

Side-by-side financial comparison of biote Corp. (BTMD) and FIRST MID BANCSHARES, INC. (FMBH). Click either name above to swap in a different company.

FIRST MID BANCSHARES, INC. is the larger business by last-quarter revenue ($88.2M vs $46.4M, roughly 1.9× biote Corp.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs 4.2%, a 22.6% gap on every dollar of revenue. On growth, FIRST MID BANCSHARES, INC. posted the faster year-over-year revenue change (3.4% vs -6.9%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $6.5M). Over the past eight quarters, FIRST MID BANCSHARES, INC.'s revenue compounded faster (5.0% CAGR vs -0.4%).

biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.

First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.

BTMD vs FMBH — Head-to-Head

Bigger by revenue
FMBH
FMBH
1.9× larger
FMBH
$88.2M
$46.4M
BTMD
Growing faster (revenue YoY)
FMBH
FMBH
+10.3% gap
FMBH
3.4%
-6.9%
BTMD
Higher net margin
FMBH
FMBH
22.6% more per $
FMBH
26.8%
4.2%
BTMD
More free cash flow
FMBH
FMBH
$117.5M more FCF
FMBH
$124.0M
$6.5M
BTMD
Faster 2-yr revenue CAGR
FMBH
FMBH
Annualised
FMBH
5.0%
-0.4%
BTMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTMD
BTMD
FMBH
FMBH
Revenue
$46.4M
$88.2M
Net Profit
$2.0M
$23.7M
Gross Margin
Operating Margin
14.7%
34.0%
Net Margin
4.2%
26.8%
Revenue YoY
-6.9%
3.4%
Net Profit YoY
-47.2%
23.5%
EPS (diluted)
$0.05
$0.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTMD
BTMD
FMBH
FMBH
Q4 25
$46.4M
$88.2M
Q3 25
$48.0M
$89.3M
Q2 25
$48.9M
$87.5M
Q1 25
$49.0M
$84.3M
Q4 24
$49.8M
$85.3M
Q3 24
$51.4M
$80.6M
Q2 24
$49.2M
$79.2M
Q1 24
$46.8M
$79.9M
Net Profit
BTMD
BTMD
FMBH
FMBH
Q4 25
$2.0M
$23.7M
Q3 25
$8.2M
$22.5M
Q2 25
$3.2M
$23.4M
Q1 25
$13.7M
$22.2M
Q4 24
$3.7M
$19.2M
Q3 24
$10.7M
$19.5M
Q2 24
$-7.1M
$19.7M
Q1 24
$-4.2M
$20.5M
Operating Margin
BTMD
BTMD
FMBH
FMBH
Q4 25
14.7%
34.0%
Q3 25
17.2%
32.2%
Q2 25
22.0%
34.4%
Q1 25
19.8%
33.4%
Q4 24
5.6%
29.7%
Q3 24
23.7%
31.5%
Q2 24
12.7%
33.7%
Q1 24
22.3%
33.7%
Net Margin
BTMD
BTMD
FMBH
FMBH
Q4 25
4.2%
26.8%
Q3 25
17.1%
25.2%
Q2 25
6.5%
26.8%
Q1 25
28.0%
26.3%
Q4 24
7.4%
22.5%
Q3 24
20.8%
24.2%
Q2 24
-14.4%
24.9%
Q1 24
-8.9%
25.6%
EPS (diluted)
BTMD
BTMD
FMBH
FMBH
Q4 25
$0.05
$0.98
Q3 25
$0.22
$0.94
Q2 25
$0.10
$0.98
Q1 25
$0.37
$0.93
Q4 24
$0.09
$0.81
Q3 24
$0.33
$0.81
Q2 24
$-0.21
$0.82
Q1 24
$-0.12
$0.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTMD
BTMD
FMBH
FMBH
Cash + ST InvestmentsLiquidity on hand
$24.1M
Total DebtLower is stronger
$103.1M
$354.5M
Stockholders' EquityBook value
$-58.5M
$958.7M
Total Assets
$107.6M
$8.0B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTMD
BTMD
FMBH
FMBH
Q4 25
$24.1M
Q3 25
$28.0M
Q2 25
$19.6M
Q1 25
$41.7M
Q4 24
$39.3M
Q3 24
$38.2M
Q2 24
$26.4M
Q1 24
$78.8M
Total Debt
BTMD
BTMD
FMBH
FMBH
Q4 25
$103.1M
$354.5M
Q3 25
$104.7M
Q2 25
$106.3M
Q1 25
$107.8M
Q4 24
$109.4M
Q3 24
$110.9M
Q2 24
$112.5M
Q1 24
$114.1M
Stockholders' Equity
BTMD
BTMD
FMBH
FMBH
Q4 25
$-58.5M
$958.7M
Q3 25
$-72.8M
$932.2M
Q2 25
$-85.1M
$894.1M
Q1 25
$-90.0M
$870.9M
Q4 24
$-105.9M
$846.4M
Q3 24
$-130.3M
$858.5M
Q2 24
$-143.2M
$813.6M
Q1 24
$-36.0M
$798.0M
Total Assets
BTMD
BTMD
FMBH
FMBH
Q4 25
$107.6M
$8.0B
Q3 25
$111.3M
$7.8B
Q2 25
$104.8M
$7.7B
Q1 25
$123.4M
$7.6B
Q4 24
$122.4M
$7.5B
Q3 24
$101.3M
$7.6B
Q2 24
$92.9M
$7.6B
Q1 24
$160.1M
$7.7B
Debt / Equity
BTMD
BTMD
FMBH
FMBH
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTMD
BTMD
FMBH
FMBH
Operating Cash FlowLast quarter
$7.6M
$130.9M
Free Cash FlowOCF − Capex
$6.5M
$124.0M
FCF MarginFCF / Revenue
14.0%
140.6%
Capex IntensityCapex / Revenue
2.3%
7.8%
Cash ConversionOCF / Net Profit
3.87×
5.53×
TTM Free Cash FlowTrailing 4 quarters
$30.2M
$207.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTMD
BTMD
FMBH
FMBH
Q4 25
$7.6M
$130.9M
Q3 25
$14.1M
$33.0M
Q2 25
$7.1M
$7.7M
Q1 25
$6.5M
$47.9M
Q4 24
$12.4M
$124.4M
Q3 24
$15.6M
$33.1M
Q2 24
$9.9M
$24.0M
Q1 24
$7.4M
$29.0M
Free Cash Flow
BTMD
BTMD
FMBH
FMBH
Q4 25
$6.5M
$124.0M
Q3 25
$13.6M
$31.9M
Q2 25
$5.3M
$6.0M
Q1 25
$4.8M
$46.0M
Q4 24
$10.7M
$119.5M
Q3 24
$14.0M
$32.0M
Q2 24
$7.4M
$22.9M
Q1 24
$6.7M
$27.6M
FCF Margin
BTMD
BTMD
FMBH
FMBH
Q4 25
14.0%
140.6%
Q3 25
28.3%
35.8%
Q2 25
10.8%
6.8%
Q1 25
9.9%
54.5%
Q4 24
21.5%
140.0%
Q3 24
27.3%
39.7%
Q2 24
15.1%
28.9%
Q1 24
14.2%
34.5%
Capex Intensity
BTMD
BTMD
FMBH
FMBH
Q4 25
2.3%
7.8%
Q3 25
1.0%
1.2%
Q2 25
3.7%
2.0%
Q1 25
3.3%
2.3%
Q4 24
3.4%
5.8%
Q3 24
3.0%
1.4%
Q2 24
5.1%
1.4%
Q1 24
1.5%
1.9%
Cash Conversion
BTMD
BTMD
FMBH
FMBH
Q4 25
3.87×
5.53×
Q3 25
1.72×
1.47×
Q2 25
2.22×
0.33×
Q1 25
0.47×
2.16×
Q4 24
3.34×
6.49×
Q3 24
1.45×
1.70×
Q2 24
1.21×
Q1 24
1.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTMD
BTMD

Product Revenue$45.3M98%
Disposable Trocars Product Revenue$1.2M3%

FMBH
FMBH

Segment breakdown not available.

Related Comparisons